Nonclassic congenital adrenal hyperplasia (NCAH) is one of the most frequent autosomal
recessive disorders in man with a prevalence ranging from 0.1% in Caucasians up to a few …

Following the introduction of life-saving glucocorticoid replacement 60 years ago, congenital
adrenal hyperplasia (CAH) has evolved from being perceived as a paediatric disorder to …

Congenital adrenal hyperplasia (CAH) is a group of disorders affecting adrenal steroid
synthesis. The most common form, 21-hydroxylase deficiency, leads to decreased …

Context As a result of the introduction of treatment with glucocorticoids and
mineralocorticoids, now 60 years ago, congenital adrenal hyperplasia has become a …

The introduction of newborn screening programmes in most Western countries for classic
congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH) enables timely …

Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is characterized by
cortisol and in some cases aldosterone deficiency associated with androgen excess. Goals …

Context: Patients with classic congenital adrenal hyperplasia (CAH) are treated with lifelong
glucocorticoids (GCs). Cardiovascular and metabolic effects of such therapy in adolescents …

Objectives Estimates of high blood pressure (BP) incidence in children with congenital
adrenal hyperplasia (CAH) vary widely; risk factors are poorly understood. We estimated …

BACKGROUND Data on blood pressure (BP) in children and adolescents with classic
congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency are conflicting in the …

Objective: Children and adolescents with classical congenital adrenal hyperplasia have
been shown to be at risk for obesity associated with higher insulin and leptin levels …